Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia

American Journal of Clinical Pathology

Volumn 124, Issue 2, 2005, Pages 170-181

  Kussick, Steven J ^a,b   Fromm, Jonathan R ^a   Rossini, Anthony ^a   Li, Ying ^a   Chang, Anthony ^a   Norwood, Thomas H ^a   Wood, Brent L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Antigen expression; Bone marrow; Cytogenetics; Flow cytometry; Myelodysplasia; Myelodysplastic syndromes

Indexed keywords

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BONE MARROW CELL; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOGENETICS; CYTOPENIA; EVALUATION; FEMALE; FLOW CYTOMETRY; FOUR COLOR FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCYTOSIS; MYELOBLAST; MYELODYSPLASIA; PATIENT SELECTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 23044435252     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/6PBP78G4FBA1FDG6     Document Type: Article

References (34)

1. Foucar K. Bone Marrow Pathology. Chicago, IL; ASCP Press; 2001:175.
2. Loken MR, Wells DA. Normal antigen expression in hematopoiesis: basis for interpreting leukemia phenotypes. In: Stewart CC, Nicholson JKA, eds. Immunophenotyping. New York, NY: Wiley-Liss; 2000:133-160.
3. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol. 1990;2:229-240.
4. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow, III: neutrophil maturation. Leukemia. 1990;4:657-663.
5. Elghetany MT. Surface marker abnormalities in myelodysplastic syndromes. Haematologica. 1998;83:1104-1115.
6. Bianco T, Farmer BJ, Sage RE, et al. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood. 2001;97:3633-3639.
7. Izumi M, Takeshita A, Shinjo K, et al. Decreased amount of mp1 and reduced expression of glycoprotein Ilb/IIIa and glycoprotein Ib on platelets from patients with refractory anemia: analysis by a non-isotopic quantitative ligand binding assay and immunofluorescence. Eur J Haematol. 2001;66:245-252.
8. Bowen KL, Davis BH. Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CRIII) in the bone marrow of patients with myelodysplastic syndrome. Lab Hematol. 1997;3:292-298.
9. Hansen I, Meyer K, Hokland P. Flow cytometric identification of myeloid disorders by asynchronous expression of the CD14 and CD66 antigens. Eur J Haematol. 1998;61639-346.
10. Chang CC, Cleveland RP. Decreased CD10-positive mature granulocytes in bone marrow from patients with myelodysplastic syndrome. Arch Pathol Lab Med. 2000;124:1152-1156.
11. Ohsaka A, Saionji K, Igari J, et al. Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes. Br J Haematol 1997;98:108-113.
12. Otawa M, Kawanishi Y, Iwase O, et al. Comparative multicolor flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia. Leuk Res. 2000;24:359-366.
13. Mann KP, DeCastro CM, Liu J, et al. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Am J Clin Pathol. 1997;107:653-660.
14. Schlesinger M, Silverman LR, Jiang JD, et al. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome. J Clin Lab Immunol. 1996;48:149-166.
15. Xu D, Schultz C, Akker Y, et al. Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia. Am J Hematol. 2003;74;9-16.
16. Cherian S, Moore J, Bantly A, et al. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry B Clin Cytom. 2005;64:9-17.
17. Parker JE, Mufti GJ, Rasool F, et al. The role of apoptosis, proliferation, and the bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood. 2000;96:3932-3938.
18. Matthes TW, Meyer G, Samii K, et al. Increased apoptosis in acquired sideroblastic anaemia. Br J Haematol. 2000;111:843-852.
19. Merchant SH, Gonchoroff NJ, Hutchison RE. Apoptotic index by annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes. Cytometry. 2001;46:28-32.
20. Boudard D, Sordet O, Vasselon C, et al. Expression and activity of caspases 1 and 3 in myelodysplastic syndromes. Leukemia. 2000;14:2045-2051.
21. Hellstrom-Lindberg E, Schmidt-Mende J, Forsblom AM, et al. Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases. Br J Haematol. 2001;112:714-726.
22. Delia D, Aiello A, Soligo D, et al. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood. 1992;79:1291-1298.
23. Boudard D, Vasselon C, Bertheas MF, et al. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes. Am J Hematol. 2002;70:115-125.
24. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98:979-987.
25. Ogata K, Nakamura K, Yokose N, et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood. 2002;100:3887-3896.
26. Maynadie M, Picard F, Husson B, et al. Immunophenotypic clustering of myelodysplastic syndromes. Blood. 2002;100:2349-2356.
27. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189-199.
28. Del Canizo MC, Fernandez ME, Lopez A, et al. Immunophenotypic analysis of myelodysplastic syndromes. Haematologica. 2003;88:402-407.
29. Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood. 2003;102:394-403.
30. Kussick SJ, Wood BL. Using four-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med. 2003;127:1140-1147.
31. Kussick SJ, Wood BL. Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders. Am J Clin Pathol. 2003;120:854-865.
32. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann N Y Acad Sci. 1993;677:265-280.
33. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of the Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:20. World Health Organization Classification of Tumours.
34. Smith WB, Guida L, Sun Q, et al. Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression. Blood. 1995;86:3938-3944.